United States · FDA National Drug Code directory
Remodulin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66302-102_b6a60240-eed2-4929-bb92-b139e8200652
- Product NDC
- 66302-102
- Form
- INJECTION, SOLUTION
- Composition / generic term
- treprostinil
- Labeler
- United Therapeutics Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20020522
- Source listing expiry
- 20271231
Source-listed ingredients
- TREPROSTINIL — 50 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 BOX (66302-102-01) / 20 mL in 1 VIAL · 66302-102-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →